AAAAAA

   
Results: 1-9 |
Results: 9
HEREDITARY AND SPORADIC OVARIAN-CANCER - GENETIC TESTING AND CLINICALIMPLICATIONS (REVIEW)
Authors: ANGIOLI R ESTAPE R MASON M PENALVER M
Citation: R. Angioli et al., HEREDITARY AND SPORADIC OVARIAN-CANCER - GENETIC TESTING AND CLINICALIMPLICATIONS (REVIEW), International journal of oncology, 12(5), 1998, pp. 1029-1034
SIGNIFICANCE OF INTRAPERITONEAL CYTOLOGY IN PATIENTS UNDERGOING RADICAL HYSTERECTOMY
Authors: ESTAPE R ANGIOLI R WAGMAN F MADRIGAL M JANICEK M GANJEIAZAR P PENALVER M AVERETTE H
Citation: R. Estape et al., SIGNIFICANCE OF INTRAPERITONEAL CYTOLOGY IN PATIENTS UNDERGOING RADICAL HYSTERECTOMY, Gynecologic oncology, 68(2), 1998, pp. 169-171
URINARY COMPLICATIONS OF MIAMI POUCH - TREND OF CONSERVATIVE MANAGEMENT
Authors: ANGIOLI R ESTAPE R CANTUARIA G MIRHASHEMI R WILLIAMS H MARTIN J PENALVER M
Citation: R. Angioli et al., URINARY COMPLICATIONS OF MIAMI POUCH - TREND OF CONSERVATIVE MANAGEMENT, American journal of obstetrics and gynecology, 179(2), 1998, pp. 343-348
ADVANCED MUCINOUS ADENOCARCINOMA IN PREGNANCY - OVARIAN VS COLORECTAL
Authors: ANGIOLI R YASIN S ESTAPE R JANICEK M ADRA A SOPO C MINHAJ M PENALVER M
Citation: R. Angioli et al., ADVANCED MUCINOUS ADENOCARCINOMA IN PREGNANCY - OVARIAN VS COLORECTAL, Oncology Reports, 4(3), 1997, pp. 501-503
GESTATIONAL TROPHOBLASTIC DISEASE IN A 51 YEAR-OLD WOMAN
Authors: CANTUARIA GHC ANGIOLI R MESSORE M ESTAPE R PENALVER M
Citation: Ghc. Cantuaria et al., GESTATIONAL TROPHOBLASTIC DISEASE IN A 51 YEAR-OLD WOMAN, Oncology Reports, 4(1), 1997, pp. 149-151
USE OF LONIDAMINE TO POTENTIATE THE EFFECT OF CISPLATIN AND CARBOPLATIN ON PLATINUM RESISTANT HUMAN OVARIAN-CANCER CELLS
Authors: ANGIOLI R JANICEK M SEVIN BU ESTAPE R AVERETTE HE KOECHLI OR UNTCH M PENALVER M
Citation: R. Angioli et al., USE OF LONIDAMINE TO POTENTIATE THE EFFECT OF CISPLATIN AND CARBOPLATIN ON PLATINUM RESISTANT HUMAN OVARIAN-CANCER CELLS, International journal of oncology, 11(4), 1997, pp. 777-780
P53 INTERFERENCE AND GROWTH-INHIBITION IN P53-MUTANT AND OVEREXPRESSING ENDOMETRIAL CANCER CELL-LINES
Authors: JANICEK MF ANGIOLI R UNAL AD SEVIN BU MADRIGAL M ESTAPE R AVERETTE HE
Citation: Mf. Janicek et al., P53 INTERFERENCE AND GROWTH-INHIBITION IN P53-MUTANT AND OVEREXPRESSING ENDOMETRIAL CANCER CELL-LINES, Gynecologic oncology, 66(1), 1997, pp. 94-102
IN-VITRO ANTIGENE THERAPY TARGETING HPV-16 E6 AND E7 IN CERVICAL-CARCINOMA
Authors: MADRIGAL M JANICEK MF SEVIN BU PERRAS J ESTAPE R PENALVER M AVERETTE HE
Citation: M. Madrigal et al., IN-VITRO ANTIGENE THERAPY TARGETING HPV-16 E6 AND E7 IN CERVICAL-CARCINOMA, Gynecologic oncology, 64(1), 1997, pp. 18-25
USE OF INTERFERON AND MEDROXYPROGESTERONE ACETATE FOR THE TREATMENT OF ENDOMETRIAL CANCER
Authors: ANGIOLI R SEVIN BU UNTCH M KOCHLI OR ESTAPE R AVERETTE HE
Citation: R. Angioli et al., USE OF INTERFERON AND MEDROXYPROGESTERONE ACETATE FOR THE TREATMENT OF ENDOMETRIAL CANCER, Oncology Reports, 3(2), 1996, pp. 351-354
Risultati: 1-9 |